Eugeni García Curto

Eugeni García Curto

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PRPedro ROMERO-AROCA
Pedro ROMERO-AROCA
RVRaquel Verges
Raquel Verges
JPJordi Pascual-Fontanilles
Jordi Pascual-Fontanilles
Aida VallsAida Valls
Aida Valls
JFJosep Franch-Nadal
Josep Franch-Nadal
BMBaget-Bernaldiz Marc
Baget-Bernaldiz Marc
(1) Background: Diabetic retinopathy (DR) remains the leading cause of low vision and blindness in young adults of working age. Although the most important risk factors—such as the duration of diabetes mellitus (DM) and glycemic control measured by HbA1c—are known, the effects of lipids are not as clear. The aim of the present study is to analyze the effects of lipids on the development of DR. (2) Methods: This is a retrospective study of a population of 175,645 DM2 patients, during the period 2010 to 2020, in which the effects of different lipid factors are studied. (3) Results: The variables that most influenced the development of DR in our study, based on significance and cumulative hazard (CH), were arterial hypertension (CH 1.217, p < 0.001), HbA1c levels (CH 1.162, p = 0.001), microalbuminuria (CH 1.012, p < 0.001), LDL-C cholesterol (CH 1.007, p = 0.012), TC/HDL-C index (CH 1.092, p < 0.001), No-HDL-C/HDL-C index (CH 1.065, p = 0.002), the use of statins (CH 1.001, p = 0.005), and body mass index (CH 1.007, p < 0.001). (4) Conclusions: LDL-cholesterol, TC/HDL-C, and No-HDL-C/HDL-C indices are related to the development of DR, and there is a protective effect of HDL-cholesterol and the use of fibrates.

30 November 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PRPedro ROMERO-AROCA
Pedro ROMERO-AROCA
BMBaget-Bernaldiz Marc
Baget-Bernaldiz Marc
RSRamon Sagarra
Ramon Sagarra
ERESTHER HERVAS ROMERO
ESTHER HERVAS ROMERO
RBReyes Blasco
Reyes Blasco
ECEugeni García Curto
Eugeni García Curto
(1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM), screening programs of which have been affected by the COVID-19 pandemic. The aim of the present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our healthcare area (HCA). (2) Methods: We carried out a retrospective study of patients with DM who had attended the DR screening program between January 2015 and June 2022. We studied attendance, DM metabolic control and DR incidence. (3) Results: Screening for DR decreased in the first few months of the pandemic. The incidence of mild and moderate DR remained stable throughout the study, and we observed little increase in severe DR, proliferative DR and neovascular glaucoma during 2021 and 2022. (4) Conclusions: The current study shows that during the COVID-19 pandemic, screening program attendance decreased during the year 2020, which then recovered in 2021. Regarding the most severe forms of DR, a slight increase in cases was observed, beginning in the year 2021. Nevertheless, we aimed to improve the telemedicine systems, since the conditions of a significant proportion of the studied patients worsened during the pandemic; these patients are likely those who were already poorly monitored.

17 April 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
PRPedro ROMERO-AROCA
Pedro ROMERO-AROCA
RVRaquel Verges
Raquel Verges
JPJordi Pascual-Fontanilles
Jordi Pascual-Fontanilles
Aida VallsAida Valls
Aida Valls
JFJosep Franch-Nadal
Josep Franch-Nadal
BMBaget-Bernaldiz Marc
Baget-Bernaldiz Marc
(1) Background: Although DR screening is effective, one of its most significant problems is a lack of attendance. The aim of the present study was to demonstrate the effectiveness of our algorithm in predicting the development of any type of DR and referable DR. (2) Methods: A retrospective study with an 11-year follow-up of a population of 120,389 T2DM patients was undertaken. (3) Results: Applying the results of the algorithm showed an AUC of 0.93 (95% CI, 0.92–0.94) for any DR and 0.90 (95% CI, 0.89–0.91) for referable DR. Therefore, we achieved a promising level of agreement when applying our algorithm. (4) Conclusions: The algorithm is useful for predicting which patients may develop referable forms of DR and also any type of DR. This would allow a personalized screening plan to be drawn up for each patient.

18 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PRPedro ROMERO-AROCA
Pedro ROMERO-AROCA
BPBenilde Fontoba Poveda
Benilde Fontoba Poveda
ECEugeni García Curto
Eugeni García Curto
Aida VallsAida Valls
Aida Valls
JCJulián Cristiano
Julián Cristiano
BMBaget-Bernaldiz Marc
Baget-Bernaldiz Marc
Background/Objectives: Telemedicine in diabetic retinopathy (RD) screening is effective but does not reach the entire diabetes population. The use of portable cameras and artificial intelligence (AI) can help in screening diabetes. Methods: We evaluated the ability of two handheld cameras, one based on a smartphone and the other on a smartscope, to obtain images for comparison with OCT. Evaluation was carried out in two stages: the first by two retina specialists and the second using an artificial intelligence algorithm that we developed. Results: The retina specialists reported that the smartphone images required mydriasis in all cases, compared to 73.05% of the smartscope images and 71.11% of the OCT images. Images were ungradable in 27.98% of the retinographs with the smartphone and in 7.98% with the smartscope. The detection of any DR using the AI algorithm showed that the smartphone obtained lower recall values (0.89) and F1 scores (0.89) than the smartscope, with 0.99. Low results were also obtained using the smartphone to detect mild DR (146 retinographs), compared to using the smartscope (218 retinographs). Conclusions: we consider that the use of handheld devices together with AI algorithms for reading retinographs can be useful for DR screening, although the ease of image acquisition through small pupils with these devices needs to be improved.

17 July 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
PRPedro ROMERO-AROCA
Pedro ROMERO-AROCA
ECEugeni García Curto
Eugeni García Curto
JPJordi Pascual-Fontanilles
Jordi Pascual-Fontanilles
Aida VallsAida Valls
Aida Valls
Antonio MorenoAntonio Moreno
Antonio Moreno
BMBaget-Bernaldiz Marc
Baget-Bernaldiz Marc
(1) Underlying Diabetic Retinopathy (DR) is the primary cause of poor vision in young adults. There are automatic image reading systems that can aid screening for DR. (2) Methods: Using our automatic reading system we have counted the number of microaneurysms and hemorrhages in the four quadrants of the ETDRS grid and evaluated the differences between them according to the type of DR. The study was carried out using data from two different databases, MESSIDOR and MIRADATASET. (3) Results: The majority of microaneurysms and hemorrhages are found in the temporal and inferior quadrants of the ETDRS grid. Differences are significant with respect to the other two quadrants at p < 0.001. Differences between the type of DR show that severe-DR has a greater number of microaneurysms and hemorrhages in the temporal and inferior quadrant, being significant at p < 0.001. (4) Conclusions: The count of microaneurysms and hemorrhages is higher in the temporal and inferior quadrants in all types of DR, and those differences are more important in the case of severe-DR.

15 November 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
PRPedro ROMERO-AROCA
Pedro ROMERO-AROCA
BMBaget-Bernaldiz Marc
Baget-Bernaldiz Marc
RSRamon Sagarra
Ramon Sagarra
ERESTHER HERVAS ROMERO
ESTHER HERVAS ROMERO
RBReyes Blasco
Reyes Blasco
ECEugeni García Curto
Eugeni García Curto
(1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM) and the COVID-19 pandemic has affected screening programmes. The aim of present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our Health Care Area (HCA); (2) Methods: A retrospective study of patients with DM who had attended the DR screening programme between January 2015 and June 2022. We studied attendance, DM metabolic control and DR incidence. (3) Results: Screening for DR decreased in the first months of the pandemic. Incidence of mild and moderate DR remained stable throughout the study, and we observed a little increase in severe-DR, proliferative-DR and neovascular glaucoma, during 2021 and 2022. (4) Conclusions: The COVID-19 pandemic caused a reduction in the number of patients screened for DM, although its effect on DR seems limited, with a similar number of patients with DR throughout 2015 to 2022, despite the number of patients with severe-DR and proliferative-DR increased in 2021 and 2022.